Address
161 Fort Washington Avenue
New York, NY 10032
US
About David J. Lederer, MD
David J. Lederer, MD, MS is the Co-Director of the New York Presbyterian/Columbia University Interstitial Lung Disease Program and Pulmonary Director of the Pulmonary & Intensive Care Translational Outcomes (PICTOR) Group at Columbia University. He is the principal investigator of two NHLBI-funded studies: the MESA Lung Fibrosis Study and the Lung Transplant Body Composition Study. He is the editor-in-chief of the Annals of the American Thoracic Society and sits on the editorial board of the American Journal of Respiratory and Critical Care Medicine. Dr. Lederer is a Senior Medical Advisor for the Pulmonary Fibrosis Foundation and a standing member of the IRAP study section at the Center ...
David J. Lederer, MD, MS is the Co-Director of the New York Presbyterian/Columbia University Interstitial Lung Disease Program and Pulmonary Director of the Pulmonary & Intensive Care Translational Outcomes (PICTOR) Group at Columbia University. He is the principal investigator of two NHLBI-funded studies: the MESA Lung Fibrosis Study and the Lung Transplant Body Composition Study. He is the editor-in-chief of the Annals of the American Thoracic Society and sits on the editorial board of the American Journal of Respiratory and Critical Care Medicine. Dr. Lederer is a Senior Medical Advisor for the Pulmonary Fibrosis Foundation and a standing member of the IRAP study section at the Center for Scientific Review at the NIH and the NHLBI K23 study section.
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Expertise
- Chronic Lung Disease
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Interstitial Pulmonary Fibrosis
- Pulmonary Fibrosis
Board Certifications
- Critical Care Medicine
- Internal Medicine
